Regulatory T Cells: From Discovery to Autoimmunity

  1. David Hafler
  1. Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut 06520
  1. Correspondence: david.hafler{at}yale.edu

Abstract

Multiple sclerosis (MS) is a genetically mediated autoimmune disease of the central nervous system. Allelic variants lead to lower thresholds of T-cell activation resulting in activation of autoreactive T cells. Environmental factors, including, among others, diet, vitamin D, and smoking, in combination with genetic predispositions, play a substantial role in disease development and activation of autoreactive T cells. FoxP3+ regulatory T cells (Tregs) have emerged as central in the control of autoreactive T cells. A consistent finding in patients with MS is defects in Treg cell function with reduced suppression of effector T cells and production of proinflammatory cytokines. Emerging data suggests that functional Tregs become effector-like T cells with loss of function associated with T-bet expression and interferon γ (IFN-γ) secretion.

Also in this Collection

    | Table of Contents

    Richard Sever interviews Joan Brugge